150 related articles for article (PubMed ID: 7240439)
1. Pharmacokinetic principles of lidocaine dosing in relation to disease state.
Waller ES
J Clin Pharmacol; 1981 Apr; 21(4):181-94. PubMed ID: 7240439
[TBL] [Abstract][Full Text] [Related]
2. Effect of the duration of infusion on the disposition of lidocaine in dogs.
LeLorier J; Moisan R; Gagné J; Caillé G
J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of lignocaine.
Benowitz NL; Meister W
Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
Sawyer DR; Ludden TM; Crawford MH
Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
[TBL] [Abstract][Full Text] [Related]
6. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
Davison R; Parker M; Atkinson AJ
Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the kinetics of tocainide in combined hepatic and renal insufficiency.
Endell W; Oltmanns D; Pottage T
Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):589-90. PubMed ID: 6420626
[No Abstract] [Full Text] [Related]
9. Lidocaine kinetics predicted by indocyanine green clearance.
Zito RA; Reid PR
N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
[TBL] [Abstract][Full Text] [Related]
10. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunction.
Oltmanns D; Pottage A; Endell W
Eur J Clin Pharmacol; 1983; 25(6):787-90. PubMed ID: 6420165
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis.
Wiegers U; Hanrath P; Kuck KH; Pottage A; Graffner C; Augustin J; Runge M
Eur J Clin Pharmacol; 1983; 24(4):503-7. PubMed ID: 6407848
[TBL] [Abstract][Full Text] [Related]
13. The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man.
Thomson PD; Rowland M; Melmon KL
Am Heart J; 1971 Sep; 82(3):417-21. PubMed ID: 5565429
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of lidocaine and its active metabolites in dogs.
Wilcke JR; Davis LE; Neff-Davis CA; Koritz GD
J Vet Pharmacol Ther; 1983 Mar; 6(1):49-57. PubMed ID: 6854732
[TBL] [Abstract][Full Text] [Related]
15. Influence of congestive heart failure on blood vessels of lidocaine and its active monodeethylated metabolite.
Halkin H; Meffin P; Melmon KL; Rowland M
Clin Pharmacol Ther; 1975 Jun; 17(6):669-76. PubMed ID: 1139858
[TBL] [Abstract][Full Text] [Related]
16. Impairment of lidocaine clearance in elderly male subjects.
Abernethy DR; Greenblatt DJ
J Cardiovasc Pharmacol; 1983; 5(6):1093-6. PubMed ID: 6196560
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics in heart failure. An updated review.
Shammas FV; Dickstein K
Clin Pharmacokinet; 1988 Aug; 15(2):94-113. PubMed ID: 3064953
[TBL] [Abstract][Full Text] [Related]
18. Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.
Powell JR; Foster J; Patterson JH; Cross R; Wargin W
Clin Pharm; 1986 Dec; 5(12):993-8. PubMed ID: 3802729
[TBL] [Abstract][Full Text] [Related]
19. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
Woosley RL; Echt DS; Roden DM
Am J Cardiol; 1986 Jan; 57(3):25B-33B. PubMed ID: 3080860
[TBL] [Abstract][Full Text] [Related]
20. [Main factors of variations in lidocaine pharmacokinetics].
Bruguerolle B; Valli M; Jadot G; Bouyard P
Therapie; 1983; 38(1):27-38. PubMed ID: 6346570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
